If the peptide restrictions are reversed through formal FDA rulemaking, compounding pharmacies would be legally allowed to prepare those peptides, but only as traditional, patient-specific compounded drugs, not as mass-market or FDA-approved therapies. If the peptides are formally added to the 503A bulk list, he says, pharmacies would have to follow the traditional 503A compounding rules
And it is exactly why where you receive peptide therapy makes all the difference
17 JonesP
[DOI] [PMC free article] [PubMed] [Google Scholar] 181.Suzuki K., Ha S.A., Tsuji M., Fagarasan S
Possibly, the similar beneficial effects in other species (i.e., birds [137] and insects [138,139,140]) may suggest that BPC 157 may also have an extended regulatory physiologic role in bodily functions